Title : Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities.

Pub. Date : 2020 Aug

PMID : 32593915






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Several pre-clinical approaches have proven successful in overcoming cisplatin resistance, including specific targeting of PARP, MDM2 or AKT/mTOR combined with cisplatin. Cisplatin AKT serine/threonine kinase 1 Homo sapiens